Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Trial of CVM150 and CVM26 Intranasal Mumps Virus Vaccines in Healthy Adults

NCT06967181 is registered in ClinicalTrials.gov with CyanVac LLC as lead sponsor.

NCT NCT06967181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06967181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Trial of CVM150 and CVM26 Intranasal Mumps Virus Vaccines in Healthy Adults
Lead sponsor
CyanVac LLC
Phase
Phase 1
Overall status
Active, not recruiting
Start date
May 14, 2025
Completion date
December 31, 2027
Enrollment
60 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mumps